Similar Articles
1381 Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection
1382 Biomarkers for the early diagnosis of hepatocellular carcinoma
1383 Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
1384 Does herbal medicine reduce the risk of hepatocellular carcinoma?
1385 Potentiality of immunotherapy against hepatocellular carcinoma
1386 Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
1387 Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
1388 Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice
1389 Liver resection for hepatocellular carcinoma using a microwave tissue coagulator: Experience of 1118 cases
1390 Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA